provider_id,hospital_name,hospital_type,address,city,state,zip_code,county_name,measure_id,measure_description,hospital_performance,denominator,footnote,rptg_prd_start_dt,rptg_prd_end_dt
50146,CITY OF HOPE HELFORD CLINICAL RESEARCH HOSPITAL,Short-term,1500 E DUARTE ROAD,DUARTE,CA,91010,Los Angeles,PCH-14,Radiation Dose Limits to Normal Tissues,100.0,33.0,nan,01/01/2016,12/31/2016
50146,CITY OF HOPE HELFORD CLINICAL RESEARCH HOSPITAL,Short-term,1500 E DUARTE ROAD,DUARTE,CA,91010,Los Angeles,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,99.0,249.0,nan,01/01/2016,12/31/2016
50146,CITY OF HOPE HELFORD CLINICAL RESEARCH HOSPITAL,Short-term,1500 E DUARTE ROAD,DUARTE,CA,91010,Los Angeles,PCH-16,Medical and Radiation - Pain Intensity Quantified,98.0,2023.0,nan,01/01/2016,12/31/2016
50146,CITY OF HOPE HELFORD CLINICAL RESEARCH HOSPITAL,Short-term,1500 E DUARTE ROAD,DUARTE,CA,91010,Los Angeles,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,100.0,35.0,nan,01/01/2016,12/31/2016
50146,CITY OF HOPE HELFORD CLINICAL RESEARCH HOSPITAL,Short-term,1500 E DUARTE ROAD,DUARTE,CA,91010,Los Angeles,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,100.0,16.0,nan,01/01/2016,12/31/2016
50660,USC KENNETH NORRIS JR CANCER HOSPITAL,Short-term,1441 EASTLAKE AVE,LOS ANGELES,CA,90089,Los Angeles,PCH-14,Radiation Dose Limits to Normal Tissues,,,5.0,01/01/2016,12/31/2016
50660,USC KENNETH NORRIS JR CANCER HOSPITAL,Short-term,1441 EASTLAKE AVE,LOS ANGELES,CA,90089,Los Angeles,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,81.0,154.0,2.0,01/01/2016,12/31/2016
50660,USC KENNETH NORRIS JR CANCER HOSPITAL,Short-term,1441 EASTLAKE AVE,LOS ANGELES,CA,90089,Los Angeles,PCH-16,Medical and Radiation - Pain Intensity Quantified,90.0,525.0,2.0,01/01/2016,12/31/2016
50660,USC KENNETH NORRIS JR CANCER HOSPITAL,Short-term,1441 EASTLAKE AVE,LOS ANGELES,CA,90089,Los Angeles,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,,,1.0,01/01/2016,12/31/2016
50660,USC KENNETH NORRIS JR CANCER HOSPITAL,Short-term,1441 EASTLAKE AVE,LOS ANGELES,CA,90089,Los Angeles,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,95.0,21.0,nan,01/01/2016,12/31/2016
100079,UNIVERSITY OF MIAMI HOSPITAL AND CLINICS,Short-term,1475 NW 12TH AVE,MIAMI,FL,33136,Miami-Dade,PCH-14,Radiation Dose Limits to Normal Tissues,,,1.0,01/01/2016,12/31/2016
100079,UNIVERSITY OF MIAMI HOSPITAL AND CLINICS,Short-term,1475 NW 12TH AVE,MIAMI,FL,33136,Miami-Dade,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,85.0,100.0,2.0,01/01/2016,12/31/2016
100079,UNIVERSITY OF MIAMI HOSPITAL AND CLINICS,Short-term,1475 NW 12TH AVE,MIAMI,FL,33136,Miami-Dade,PCH-16,Medical and Radiation - Pain Intensity Quantified,100.0,533.0,2.0,01/01/2016,12/31/2016
100079,UNIVERSITY OF MIAMI HOSPITAL AND CLINICS,Short-term,1475 NW 12TH AVE,MIAMI,FL,33136,Miami-Dade,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,100.0,19.0,nan,01/01/2016,12/31/2016
100079,UNIVERSITY OF MIAMI HOSPITAL AND CLINICS,Short-term,1475 NW 12TH AVE,MIAMI,FL,33136,Miami-Dade,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,,,1.0,01/01/2016,12/31/2016
100271,H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE I,Short-term,12902 MAGNOLIA DR,TAMPA,FL,33612,Hillsborough,PCH-14,Radiation Dose Limits to Normal Tissues,100.0,44.0,2.0,01/01/2016,12/31/2016
100271,H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE I,Short-term,12902 MAGNOLIA DR,TAMPA,FL,33612,Hillsborough,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,95.0,100.0,nan,01/01/2016,12/31/2016
100271,H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE I,Short-term,12902 MAGNOLIA DR,TAMPA,FL,33612,Hillsborough,PCH-16,Medical and Radiation - Pain Intensity Quantified,97.0,422.0,2.0,01/01/2016,12/31/2016
100271,H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE I,Short-term,12902 MAGNOLIA DR,TAMPA,FL,33612,Hillsborough,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,100.0,27.0,nan,01/01/2016,12/31/2016
100271,H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE I,Short-term,12902 MAGNOLIA DR,TAMPA,FL,33612,Hillsborough,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,100.0,26.0,nan,01/01/2016,12/31/2016
220162,DANA-FARBER CANCER INSTITUTE,Short-term,450 BROOKLINE AVENUE,BOSTON,MA,02115,Suffolk,PCH-14,Radiation Dose Limits to Normal Tissues,,,1.0,01/01/2016,12/31/2016
220162,DANA-FARBER CANCER INSTITUTE,Short-term,450 BROOKLINE AVENUE,BOSTON,MA,02115,Suffolk,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,100.0,23.0,nan,01/01/2016,12/31/2016
220162,DANA-FARBER CANCER INSTITUTE,Short-term,450 BROOKLINE AVENUE,BOSTON,MA,02115,Suffolk,PCH-16,Medical and Radiation - Pain Intensity Quantified,99.0,120.0,2.0,01/01/2016,12/31/2016
220162,DANA-FARBER CANCER INSTITUTE,Short-term,450 BROOKLINE AVENUE,BOSTON,MA,02115,Suffolk,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,,,5.0,01/01/2016,12/31/2016
220162,DANA-FARBER CANCER INSTITUTE,Short-term,450 BROOKLINE AVENUE,BOSTON,MA,02115,Suffolk,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,,,5.0,01/01/2016,12/31/2016
330154,MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES,Short-term,1275 YORK AVENUE,NEW YORK,NY,10021,New York,PCH-14,Radiation Dose Limits to Normal Tissues,100.0,18.0,nan,01/01/2016,12/31/2016
330154,MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES,Short-term,1275 YORK AVENUE,NEW YORK,NY,10021,New York,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,93.0,100.0,nan,01/01/2016,12/31/2016
330154,MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES,Short-term,1275 YORK AVENUE,NEW YORK,NY,10021,New York,PCH-16,Medical and Radiation - Pain Intensity Quantified,98.0,426.0,2.0,01/01/2016,12/31/2016
330154,MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES,Short-term,1275 YORK AVENUE,NEW YORK,NY,10021,New York,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,100.0,32.0,2.0,01/01/2016,12/31/2016
330154,MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES,Short-term,1275 YORK AVENUE,NEW YORK,NY,10021,New York,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,100.0,34.0,2.0,01/01/2016,12/31/2016
330354,ROSWELL PARK CANCER INSTITUTE,Short-term,ELM AND CARLTON STREETS,BUFFALO,NY,14203,Erie,PCH-14,Radiation Dose Limits to Normal Tissues,100.0,261.0,nan,01/01/2016,12/31/2016
330354,ROSWELL PARK CANCER INSTITUTE,Short-term,ELM AND CARLTON STREETS,BUFFALO,NY,14203,Erie,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,98.0,121.0,nan,01/01/2016,12/31/2016
330354,ROSWELL PARK CANCER INSTITUTE,Short-term,ELM AND CARLTON STREETS,BUFFALO,NY,14203,Erie,PCH-16,Medical and Radiation - Pain Intensity Quantified,94.0,500.0,2.0,01/01/2016,12/31/2016
330354,ROSWELL PARK CANCER INSTITUTE,Short-term,ELM AND CARLTON STREETS,BUFFALO,NY,14203,Erie,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,98.0,48.0,nan,01/01/2016,12/31/2016
330354,ROSWELL PARK CANCER INSTITUTE,Short-term,ELM AND CARLTON STREETS,BUFFALO,NY,14203,Erie,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,,,1.0,01/01/2016,12/31/2016
360242,JAMES CANCER HOSPITAL & SOLOVE RESEARCH INSTITUTE,Short-term,460 WEST TENTH AVENUE,COLUMBUS,OH,43210,Franklin,PCH-14,Radiation Dose Limits to Normal Tissues,100.0,11.0,nan,01/01/2016,12/31/2016
360242,JAMES CANCER HOSPITAL & SOLOVE RESEARCH INSTITUTE,Short-term,460 WEST TENTH AVENUE,COLUMBUS,OH,43210,Franklin,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,97.0,103.0,nan,01/01/2016,12/31/2016
360242,JAMES CANCER HOSPITAL & SOLOVE RESEARCH INSTITUTE,Short-term,460 WEST TENTH AVENUE,COLUMBUS,OH,43210,Franklin,PCH-16,Medical and Radiation - Pain Intensity Quantified,100.0,239.0,2.0,01/01/2016,12/31/2016
360242,JAMES CANCER HOSPITAL & SOLOVE RESEARCH INSTITUTE,Short-term,460 WEST TENTH AVENUE,COLUMBUS,OH,43210,Franklin,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,98.0,49.0,nan,01/01/2016,12/31/2016
360242,JAMES CANCER HOSPITAL & SOLOVE RESEARCH INSTITUTE,Short-term,460 WEST TENTH AVENUE,COLUMBUS,OH,43210,Franklin,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,100.0,22.0,nan,01/01/2016,12/31/2016
390196,HOSPITAL OF THE FOX CHASE CANCER CENTER,Short-term,333 COTTMAN AVENUE,PHILADELPHIA,PA,19111,Philadelphia,PCH-14,Radiation Dose Limits to Normal Tissues,100.0,67.0,nan,01/01/2016,12/31/2016
390196,HOSPITAL OF THE FOX CHASE CANCER CENTER,Short-term,333 COTTMAN AVENUE,PHILADELPHIA,PA,19111,Philadelphia,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,97.0,233.0,2.0,01/01/2016,12/31/2016
390196,HOSPITAL OF THE FOX CHASE CANCER CENTER,Short-term,333 COTTMAN AVENUE,PHILADELPHIA,PA,19111,Philadelphia,PCH-16,Medical and Radiation - Pain Intensity Quantified,97.0,600.0,2.0,01/01/2016,12/31/2016
390196,HOSPITAL OF THE FOX CHASE CANCER CENTER,Short-term,333 COTTMAN AVENUE,PHILADELPHIA,PA,19111,Philadelphia,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,100.0,28.0,nan,01/01/2016,12/31/2016
390196,HOSPITAL OF THE FOX CHASE CANCER CENTER,Short-term,333 COTTMAN AVENUE,PHILADELPHIA,PA,19111,Philadelphia,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,100.0,33.0,nan,01/01/2016,12/31/2016
450076,"UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER,THE",Short-term,1515 HOLCOMBE BLVD,HOUSTON,TX,77030,Harris,PCH-14,Radiation Dose Limits to Normal Tissues,100.0,100.0,2.0,01/01/2016,12/31/2016
450076,"UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER,THE",Short-term,1515 HOLCOMBE BLVD,HOUSTON,TX,77030,Harris,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,100.0,100.0,2.0,01/01/2016,12/31/2016
450076,"UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER,THE",Short-term,1515 HOLCOMBE BLVD,HOUSTON,TX,77030,Harris,PCH-16,Medical and Radiation - Pain Intensity Quantified,100.0,216.0,2.0,01/01/2016,12/31/2016
450076,"UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER,THE",Short-term,1515 HOLCOMBE BLVD,HOUSTON,TX,77030,Harris,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,100.0,95.0,nan,01/01/2016,12/31/2016
450076,"UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER,THE",Short-term,1515 HOLCOMBE BLVD,HOUSTON,TX,77030,Harris,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,100.0,32.0,nan,01/01/2016,12/31/2016
500138,SEATTLE CANCER CARE ALLIANCE,Short-term,825 EASTLAKE AVENUE EAST,SEATTLE,WA,98109,King,PCH-14,Radiation Dose Limits to Normal Tissues,,,1.0,01/01/2016,12/31/2016
500138,SEATTLE CANCER CARE ALLIANCE,Short-term,825 EASTLAKE AVENUE EAST,SEATTLE,WA,98109,King,PCH-15,Plan of Care for Pain - Medical Oncology and Radiation Oncology,93.0,150.0,nan,01/01/2016,12/31/2016
500138,SEATTLE CANCER CARE ALLIANCE,Short-term,825 EASTLAKE AVENUE EAST,SEATTLE,WA,98109,King,PCH-16,Medical and Radiation - Pain Intensity Quantified,95.0,463.0,2.0,01/01/2016,12/31/2016
500138,SEATTLE CANCER CARE ALLIANCE,Short-term,825 EASTLAKE AVENUE EAST,SEATTLE,WA,98109,King,PCH-17,Adjuvant Hormonal Therapy for High Risk Prostate Cancer Patients,100.0,18.0,nan,01/01/2016,12/31/2016
500138,SEATTLE CANCER CARE ALLIANCE,Short-term,825 EASTLAKE AVENUE EAST,SEATTLE,WA,98109,King,PCH-18,Avoidance of Overuse Measure - Bone Scan for Staging Low Risk Prostate Cancer Patients,,,1.0,01/01/2016,12/31/2016